Figures & data
Table 1. Patient attrition for inclusion in the european cohorts of prevalent and incident users of the extemporaneous combination of nebivolol and amlodipine (NA-EXC).
Table 2. Clinical characteristics of incident users of the extemporaneous combination of nebivolol and amlodipine in Italy and Germany.
Figure 2. Incident users of the extemporaneous combination of nebivolol and amlodipine stratified by sex.
![Figure 2. Incident users of the extemporaneous combination of nebivolol and amlodipine stratified by sex.](/cms/asset/433cd5df-8793-4a11-b2ce-5af79084ef85/icmo_a_2328652_f0002_b.jpg)
Figure 3. Incident users of the extemporaneous combination of nebivolol and amlodipine stratified by age group.
![Figure 3. Incident users of the extemporaneous combination of nebivolol and amlodipine stratified by age group.](/cms/asset/824825f2-72f0-4a13-b567-8f18a0cb7a6b/icmo_a_2328652_f0003_b.jpg)
Figure 4. Incident users of the extemporaneous combination of nebivolol and amlodipine stratified by amlodipine dosage.
![Figure 4. Incident users of the extemporaneous combination of nebivolol and amlodipine stratified by amlodipine dosage.](/cms/asset/23d7e970-2034-4a77-b582-3b8206796f65/icmo_a_2328652_f0004_b.jpg)
Table 3. Adherence to treatment of incident users of the extemporaneous combination of nebivolol and amlodipine in Italy and Germany.